Cholinergic Activity and Amyloid Precursor Protein Processing in Aging and Alzheimer's Disease

E-ISSN： 2212-5299|3|2|137-152

ISSN： 1568-007X

Source： Current Drug Targets-CNS & Neurological Disorders, Vol.3, Iss.2, 2004-04, pp. : 137-152

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Intracellular Domain of Amyloid Precursor Protein is a Potential Therapeutic Target in Alzheimer’s Disease

Current Drug Discovery Technologies, Vol. 11, Iss. 4, 2014-01 ,pp. : 243-258

Bentham Science Publishers

Access to resources Recommend Favorite

Alzheimer’s disease: towards therapeutic manipulation of the amyloid precursor protein and amyloid &bgr;-peptides

By Larner A.J. Rossor M.N.

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 10, 1997-10 ,pp. : 1115-1127

Informa Healthcare

Access to resources Recommend Favorite

Defective protein kinase C [alpha ] and [beta ]-amyloid precursor protein secretion in fibroblasts from sporadic Alzheimer's disease patients

By Govoni S. Bergamaschi S. Trabucchi M. Battaini F. Binetti G. Bianchetti A. Racchi M.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 206-206

Elsevier

Access to resources Recommend Favorite

Platelets as a peripheral district where to study pathogenetic mechanisms of Alzheimer disease: the case of amyloid precursor protein

By Di Luca M. Colciaghi F. Pastorino L. Borroni B. Padovani A. Cattabeni F.

European Journal of Pharmacology, Vol. 405, Iss. 1, 2000-09 ,pp. : 277-283

Elsevier

Access to resources Recommend Favorite

The Amyloid &bgr;-Protein Precursor and Alzheimer's Disease. Therapeutic Approaches

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 5, Iss. 4, 2005-12 ,pp. : 271-283

Bentham Science Publishers

Access to resources Recommend Favorite